Critically, low CHAC1 expression confers resistance to ferroptosis in several cancers, including hepatocellular carcinoma, gastric cancer, prostate cancer, and oral squamous cell carcinoma. The gene discussed is CHAC1; the disease is hepatocellular carcinoma.